Compugen Ltd CGEN.OQ, CGEN.O is expected to show a rise in quarterly revenue when it reports results on May 19 for the period ending March 31 2025
The Holon Israel-based company is expected to report a 44.7% increase in revenue to $3.704 million from $2.56 million a year ago, according to the mean estimate from 2 analysts, based on LSEG data.
LSEG's mean analyst estimate for Compugen Ltd is for a loss of 5 cents per share.
The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Compugen Ltd is $4.00, above its last closing price of $1.37.
This summary was machine generated May 16 at 12:50 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)